TNF and lung disorder: Our results show that both SAHA and TSA significantly inhibits (p < 0.05) TNFα-induced NFκB and IL-8 reporter activities (Fig. 1b and c), suggesting that HDACi has the potential to control TNFα-induced inflammation and/or chronic CF-lung disease.